186 related articles for article (PubMed ID: 29960767)
1. Acceptability of Multiple Uncoated Minitablets in Infants and Toddlers: A Randomized Controlled Trial.
Klingmann V; Linderskamp H; Meissner T; Mayatepek E; Moeltner A; Breitkreutz J; Bosse HM
J Pediatr; 2018 Oct; 201():202-207.e1. PubMed ID: 29960767
[TBL] [Abstract][Full Text] [Related]
2. Acceptability of small-sized oblong tablets in comparison to syrup and mini-tablets in infants and toddlers: A randomized controlled trial.
Münch J; Meissner T; Mayatepek E; Wargenau M; Breitkreutz J; Bosse HM; Klingmann V
Eur J Pharm Biopharm; 2021 Sep; 166():126-134. PubMed ID: 34153451
[TBL] [Abstract][Full Text] [Related]
3. Acceptability of Uncoated Mini-Tablets in Neonates--A Randomized Controlled Trial.
Klingmann V; Seitz A; Meissner T; Breitkreutz J; Moeltner A; Bosse HM
J Pediatr; 2015 Oct; 167(4):893-896.e2. PubMed ID: 26259675
[TBL] [Abstract][Full Text] [Related]
4. Acceptability of an orodispersible film compared to syrup in neonates and infants: A randomized controlled trial.
Klingmann V; Pohly CE; Meissner T; Mayatepek E; Möltner A; Flunkert K; Breitkreutz J; Bosse HM
Eur J Pharm Biopharm; 2020 Jun; 151():239-245. PubMed ID: 32348882
[TBL] [Abstract][Full Text] [Related]
5. Acceptability of multiple coated mini-tablets in comparison to syrup in infants and toddlers: a randomised controlled study.
Klingmann V; Hinder M; Langenickel TH; Chen F; Khder Y; Breitkreutz J; Bosse HM
Arch Dis Child; 2023 Sep; 108(9):730-735. PubMed ID: 36963813
[TBL] [Abstract][Full Text] [Related]
6. Acceptability of Mini-Tablets in Young Children: Results from Three Prospective Cross-over Studies.
Klingmann V
AAPS PharmSciTech; 2017 Feb; 18(2):263-266. PubMed ID: 27714698
[TBL] [Abstract][Full Text] [Related]
7. Favorable acceptance of mini-tablets compared with syrup: a randomized controlled trial in infants and preschool children.
Klingmann V; Spomer N; Lerch C; Stoltenberg I; Frömke C; Bosse HM; Breitkreutz J; Meissner T
J Pediatr; 2013 Dec; 163(6):1728-1732.e1. PubMed ID: 23972645
[TBL] [Abstract][Full Text] [Related]
8. Can preschool-aged children swallow several minitablets at a time? Results from a clinical pilot study.
Kluk A; Sznitowska M; Brandt A; Sznurkowska K; Plata-Nazar K; Mysliwiec M; Kaminska B; Kotlowska H
Int J Pharm; 2015 May; 485(1-2):1-6. PubMed ID: 25735666
[TBL] [Abstract][Full Text] [Related]
9. Paediatric solid oral dosage forms for combination products: Improving in vitro swallowability of minitablets using binary mixtures with pellets.
Avila-Sierra A; Lavoisier A; Timpe C; Kuehl P; Wagner L; Tournier C; Ramaioli M
Eur J Pharm Sci; 2023 Aug; 187():106471. PubMed ID: 37210000
[TBL] [Abstract][Full Text] [Related]
10. Evidence of acceptability of oral paediatric medicines: a review.
Mistry P; Batchelor H;
J Pharm Pharmacol; 2017 Apr; 69(4):361-376. PubMed ID: 27524471
[TBL] [Abstract][Full Text] [Related]
11. Acceptance of uncoated mini-tablets in young children: results from a prospective exploratory cross-over study.
Spomer N; Klingmann V; Stoltenberg I; Lerch C; Meissner T; Breitkreutz J
Arch Dis Child; 2012 Mar; 97(3):283-6. PubMed ID: 22253279
[TBL] [Abstract][Full Text] [Related]
12. Swallowability of Minitablets among Children Aged 6-23 Months: An Exploratory, Randomized Crossover Study.
Mitsui N; Hida N; Kamiya T; Yamazaki T; Miyazaki K; Saito K; Saito J; Yamatani A; Ishikawa Y; Nakamura H; Nakamura A; Harada T
Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057092
[TBL] [Abstract][Full Text] [Related]
13. Acceptability of different oral formulations in infants and preschool children.
van Riet-Nales DA; de Neef BJ; Schobben AF; Ferreira JA; Egberts TC; Rademaker CM
Arch Dis Child; 2013 Sep; 98(9):725-31. PubMed ID: 23853004
[TBL] [Abstract][Full Text] [Related]
14. Age-appropriate solid oral formulations for pediatric applications with a focus on multiparticulates and minitablets: Summary of September 2019 EuPFI workshop.
Harris D; Hermans E; Klein S; Wagner-Hattler L; Walsh J
Eur J Pharm Biopharm; 2020 Aug; 153():222-225. PubMed ID: 32580052
[TBL] [Abstract][Full Text] [Related]
15. Methods of administering oral formulations and child acceptability.
van Riet-Nales DA; Ferreira JA; Schobben AF; de Neef BJ; Egberts TC; Rademaker CM
Int J Pharm; 2015 Aug; 491(1-2):261-7. PubMed ID: 26143234
[TBL] [Abstract][Full Text] [Related]
16. Drug Formulations: Standards and Novel Strategies for Drug Administration in Pediatrics.
Thabet Y; Klingmann V; Breitkreutz J
J Clin Pharmacol; 2018 Oct; 58 Suppl 10():S26-S35. PubMed ID: 30248193
[TBL] [Abstract][Full Text] [Related]
17. Preparation of multiple-unit floating-bioadhesive cooperative minitablets for improving the oral bioavailability of famotidine in rats.
Zhu X; Qi X; Wu Z; Zhang Z; Xing J; Li X
Drug Deliv; 2014 Sep; 21(6):459-66. PubMed ID: 24456044
[TBL] [Abstract][Full Text] [Related]
18. Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspects.
van Riet-Nales DA; Schobben AF; Vromans H; Egberts TC; Rademaker CM
Arch Dis Child; 2016 Jul; 101(7):662-9. PubMed ID: 26979250
[TBL] [Abstract][Full Text] [Related]
19. Influence of the geometry of 3D printed solid oral dosage forms on their swallowability.
Bogdahn M; Torner J; Krause J; Grimm M; Weitschies W
Eur J Pharm Biopharm; 2021 Oct; 167():65-72. PubMed ID: 34298113
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the Acceptability, Swallowability, and Palatability of Film-Coated Mini-Tablet Formulation in Young Children: Results from an Open-Label, Single-Dose, Cross-Over Study.
Münch J; Sessler I; Bosse HM; Wargenau M; Dreesen JD; Loforese G; Webb NJA; Sivasubramanian R; Reidemeister S; Lustenberger P; Klingmann V
Pharmaceutics; 2023 Jun; 15(6):. PubMed ID: 37376177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
